ArticleInvestigative and clinical urology2025
Descriptive analysis of initial experience with partial nephrectomy and retroperitoneal organ surgery using supine anterior retroperitoneal approach with the da Vinci SP robotic system: Pilot cases.
Article in Investigative and clinical urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the feasibility, safety, and perioperative outcomes of the supine anterior retroperitoneal approach (SARA) using the da Vinci single-port (SP) robotic system for partial nephrectomy (PN) and retroperitoneal organ surgeries. MATERIALS AND
methodsFrom December 2023 to December 2024, 35 retroperitoneal surgeries, including 25 PN and 10 other procedures (e.g., adrenalectomy, pyeloplasty, ureterectomy), were performed via SARA with the da Vinci SP system by a single surgeon. Patient demographics, operative details, renal function, and postoperative recovery parameters were analyzed.
resultsThe mean patient age was 60.3 years, with a body mass index of 24.8. The mean operative time was 203.1 minutes, and mean console time was 141.9 minutes. Estimated blood loss was 330.4 mL, with minimal hemoglobin drop and renal function decline. No conversions to open surgery or major complications were observed. Postoperative pain was mild (mean numeric rating scale 2.5), and bowel function returned within 1.7 days. Tumor size averaged 3.5 cm, with most being clear cell carcinoma. SARA proved effective for upper and lower pole masses, and for adrenal or ureteral surgeries.
conclusionsThe SARA technique using the da Vinci SP robotic system is a safe and feasible approach for PN and various retroperitoneal procedures. It allows for minimal invasiveness, low complication rates, and rapid recovery. Further studies are needed to validate these findings and define the learning curve.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.